Disease modifying therapies

Disease modifying therapies (DMTs) aren't a cure for MS. But they can make a real difference to many people’s MS. 

DMTs can change for the better how MS develops over time. Most of them work against relapsing remitting MS. But we now also have DMTs for some types of progressive MS

These treatments reduce how many relapses you get. If you get a relapse in the future, it’s likely to be less serious. DMTs can slow down the damage caused by MS that builds up over time. Some people might even see some of their symptoms get better to some degree. But DMTs can’t undo damage to nerves that’s left you with a serious disability.

How do DMTs for MS work?

DMTs change how your immune system behaves. Your immune system causes inflammation to nerves in your brain or spinal cord. DMTs dampen down this inflammation. If it’s left untreated, inflammation will damage these nerves. 

Your immune system also launches attacks on these nerves. That’s what a relapse is. During these attacks the fatty myelin coating around the nerves gets stripped away. This damaged myelin is what then causes symptoms of MS. 

DMTs stop these attacks. That means you not only get fewer relapses, but also fewer lesions. These are areas of nerve damage seen on scans of your brain or spinal cord. DMTs also slow down how fast your disability or symptoms gets worse over time.

How many DMTs are there for MS?

There are around 20 DMTs for MS now available in the UK on the NHS. They come as pills, injections or infusions (a ‘drip’). One treatment called HSCT is a stem cell therapy. Sometimes you’ll also hear DMTs called ‘disease modifying drugs’ or DMDs.

Generic and biosimilar DMTs

A growing number of DMTs for MS now come with either ‘generic’ or ‘biosimilar’ versions. These are either identical or very similar versions of the original MS drug they’re based on. Generic drugs are identical to the original drug. Biosimilar drugs are very similar to the original drug.

Read about generic and biosimilar DMTs

DMT decision tool

Our DMT decision tool is here to help you explore your DMT options. It can help you be more ready for conversations about treatment with your neurologist or MS nurse.

Try our DMT decision tool

 

Explore disease modifying treatments for MS

Alemtuzumab is a disease modifying therapy (DMT) for very active relapsing MS. Its brand name is Lemtrada. You take it as an infusion. Most people only ever need two infusions.

Read more about alemtuzumab

Avonex is a disease modifying therapy (DMT) for relapsing MS. It’s a brand name of one of the beta interferon drugs. You inject it into a muscle once a week.

Read more about the beta interferons

Cladribine is a disease modifying therapy (DMT) for active and very active relapsing MS. Its brand name is Mavenclad. You take it as just two courses of tablets a year apart. 

Read more about cladribine

Dimethyl fumarate is a disease modifying therapy (DMT) for active relapsing MS. Its brand name is Tecfidera. You take it as a tablet twice a day.

Read more about dimethyl fumarate

Diroximal fumarate is a disease modifying therapy (DMT) for active relapsing MS. Its brand name is Vumerity. You take it as a tablet twice a day.

Read more about diroximel fumarate

Fingolimod is a disease modifying therapy (DMT) for very active relapsing MS. Its brand name is Gilenya. You take it as a tablet once a day.

Read more about fingolimod

Glatiramer acetate is a disease modifying therapy (DMT) forrelapsing MS. Its brand names are Copaxone and Brabio. You inject it under the skin once a day or three times a week, depending on the dose.

Read more about glatiramer acetate

Haematopoietic stem cell transplantation (HSCT) is an intense chemotherapy treatment for very active MS. It aims to stop the damage MS causes by wiping out and then regrowing your immune system. It does this by using your own stem cells.

Read more about HSCT

Natalizumab is a disease modifying therapy (DMT) for very active relapsing MS. Its brand names are Tysabri and Tyruko. You take Tysabri usually every four weeks. This is by injection under the skin given by a nurse or by infusion. Tyruko only comes as an infusion, which you have every four weeks.

Read more about natalizumab

Ocrelizumab is a disease modifying therapy (DMT) for active relapsing MS. It can also treat early active primary progressive MS. Its brand name is Ocrevus. You have it every six months, either as an infusion or injection under the skin. 

Read more about ocrelizumab

Ofatumumab is a disease modifying therapy (DMT) for active relapsing MS. Its brand name is Kesimpta. You inject it under the skin once a month. 

Read more about ofatumumab

Ozanimod is a disease modifying therapy (DMT) for active relapsing MS. Its brand name is Zeposia. You take it as a tablet once a day. It’s only available in Scotland.

Read more about ozanimod

Plegridy is a disease modifying therapy (DMT) for relapsing MS. It’s a brand name of one of the beta interferon drugs. You inject it under the skin or into muscle every two weeks.

Read more about the beta interferons

Ponesimod is a disease modifying therapy (DMT) for active relapsing MS. Its brand name is Ponvory. You take it as a tablet once a day.

Read more about ponesimod

Rebif is a disease modifying therapy (DMT) for relapsing MS. It’s a brand name of one of the beta interferon drugs. You take it as an injection three times a week.

Read more about the beta interferons

Siponimod is a disease modifying therapy (DMT) for active secondary progressive MS. Its brand name is Mayzent. You take it as a tablet once a day.

Read more about siponimod

Teriflunomide is a disease modifying therapy (DMT) for active relapsing MS. Its brand name is Aubagio. You take it as a tablet once a day.

Read more about teriflunomide

Ublituximab is a disease modifying therapy (DMT) for active relapsing MS. Its brand name is Briumvi. You take it as an infusion twice a year.

Read more about ublituximab

Last full review: 1 May 2026
Next review date: 1 May 2029 

We also update when we know about important changes.

Find out how we keep our information up to date